The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

NCT00827554 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: LMWH
PROCEDURE: TACE

Sponsor

Eastern Hepatobiliary Surgery Hospital